Remove tag ms
article thumbnail

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US

Pharmaceutical Technology

Multiple sclerosis (MS) is a primary autoimmune disease in which inflammation is a core contributor to the degeneration of the central nervous system (CNS), leading to neurological disability and affecting sensory, visual, motor, and autonomic systems. DMTs for MS have a high price tag, particularly in the US.

Marketing 246
article thumbnail

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

With a lot of money pouring in from MS drugs, their CEO decided that they needed to act like big pharma and moved the company to downtown Cambridge under the guise that it was necessary to get closer to biomedical R&D. If the drug is approved you can bet that it’s going to carry a huge price tag.

Drugs 187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS

Pharma Tutor

Sayyed , Ms. A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS. About Authors. 1,2,3,4 Sahyadri College of Pharmacy Methwade Tal, Sangola, Distsolapur Maharashtra 413307. Wed, 07/13/2022 - 15:34. Review Articles.

article thumbnail

What is Biogen and can they repair their reputation?

World of DTC Marketing

They had a new MS drug that was the talk of the industry and an exciting pipeline. Then they decided to move their HQ to an expensive campus in downtown Cambridge to play with “big pharma” Along with the move came new competitors and MS patients who reported that other MS drugs were better.

Drugs 222
article thumbnail

June 24, 2022: FDA Draft Guidance on Real-World Evidence (John Concato, MD, MS, MPH)

Rethinking Clinical Trials

John Concato, MD, MS, MPH. The post June 24, 2022: FDA Draft Guidance on Real-World Evidence (John Concato, MD, MS, MPH) appeared first on Rethinking Clinical Trials. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speaker. Associate Director for Real-World Evidence Analytics.

Big Data 130
article thumbnail

Healthcare doesn’t give a damn about patients

World of DTC Marketing

Pfizer, for instance, hiked the cost of its leukemia medication Besponsa again this month, bringing its per-vial price tag to $21,056. Ms are raking in billions, and salaries within the industry have skyrocketed to where even Directors are making higher salaries than other industry averages. million in total compensation.

Packaging 183
article thumbnail

Are RXBars Healthy? An In-Depth Look at the Trending Protein Bar

XTalks

So, what justifies such a hefty price tag and are RXBars healthy? RXBars have become a focal point in the protein bar sector, primarily driven by a surge in health-conscious consumers. The brand’s popularity reached new heights when Kellogg’s acquired the company for an impressive $600 million in 2017.

Protein 59